Data Hint B.1.1.7 Could Be More Deadly Than Thought

In addition to being more transmissible, the variant now dominant in the UK may be about 30 percent more deadly than previous strains, but much uncertainty remains.

| 2 min read
a sign reading "Please keep your distance"

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, LAURENCE BERGER

Update (March 10): One of the studies included in the NERVTAG report has been published in The BMJ today with expanded data. The researchers compared more than 100,000 people who tested positive for either B.1.1.7 or other SARS-CoV-2 variants, and found that B.1.1.7 was associated with a 32–104 percent increased risk of death within 28 days.

The B.1.1.7 variant of SARS-CoV-2, which was first found in September and is now dominant in the UK and present in many other countries, is thought to be more easily transmitted than other variants are. It might also be more deadly. UK Prime Minister Boris Johnson announced at a news conference on Friday (January 22) that new data indicate B.1.1.7 may be 30 percent more fatal.

The evidence comes from two analyses reviewed by a government committee called the New and Emerging Respiratory Virus Threats, or NERVTAG. Patrick Vallance, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb